Literature DB >> 30858322

Profile of Daniel A. Haber.

Beth Azar.   

Abstract

Mesh：

Year:  2019        PMID： 30858322      PMCID： PMC6442625          DOI： 10.1073/pnas.1903223116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Authors:  Miguel N Rivera; Woo Jae Kim; Julie Wells; David R Driscoll; Brian W Brannigan; Moonjoo Han; James C Kim; Andrew P Feinberg; William L Gerald; Sara O Vargas; Lynda Chin; A John Iafrate; Daphne W Bell; Daniel A Haber
Journal:  Science       Date:  2007-01-04       Impact factor: 47.728

2.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomes.

Authors:  D A Haber; R T Schimke
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

4.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

5.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

6.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Authors:  M G FitzGerald; D J MacDonald; M Krainer; I Hoover; E O'Neil; H Unsal; S Silva-Arrieto; D M Finkelstein; P Beer-Romero; C Englert; D C Sgroi; B L Smith; J W Younger; J E Garber; R B Duda; K A Mayzel; K J Isselbacher; S H Friend; D A Haber
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

7.  COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis.

Authors:  Yu Zheng; Valentine Comaills; Risa Burr; Gaylor Boulay; David T Miyamoto; Ben S Wittner; Erin Emmons; Srinjoy Sil; Michael W Koulopoulos; Katherine T Broderick; Eric Tai; Shruthi Rengarajan; Anupriya S Kulkarni; Toshi Shioda; Chin-Lee Wu; Sridhar Ramaswamy; David T Ting; Mehmet Toner; Miguel N Rivera; Shyamala Maheswaran; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-28       Impact factor: 11.205

8.  Detection of mutations in EGFR in circulating lung-cancer cells.

Authors:  Shyamala Maheswaran; Lecia V Sequist; Sunitha Nagrath; Lindsey Ulkus; Brian Brannigan; Chey V Collura; Elizabeth Inserra; Sven Diederichs; A John Iafrate; Daphne W Bell; Subba Digumarthy; Alona Muzikansky; Daniel Irimia; Jeffrey Settleman; Ronald G Tompkins; Thomas J Lynch; Mehmet Toner; Daniel A Haber
Journal:  N Engl J Med       Date:  2008-07-02       Impact factor: 91.245

9.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

10.  Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

Authors:  Min Yu; Aditya Bardia; Nicola Aceto; Francesca Bersani; Marissa W Madden; Maria C Donaldson; Rushil Desai; Huili Zhu; Valentine Comaills; Zongli Zheng; Ben S Wittner; Petar Stojanov; Elena Brachtel; Dennis Sgroi; Ravi Kapur; Toshihiro Shioda; David T Ting; Sridhar Ramaswamy; Gad Getz; A John Iafrate; Cyril Benes; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber
Journal:  Science       Date:  2014-07-11       Impact factor: 47.728
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.